Go to main content

Challenging governments and uninformed campaigns

“You should develop a safer product.” For decades, that is what governments and the public health community have told the tobacco industry. Philip Morris International (PMI) has invested billions of dollars in science and technology to achieve that precise objective.

Campaigns, some funded by American special interest groups, are dedicated to just one mission. Under the guise of promoting public health, they are depriving adults who smoke of their right to choose scientifically substantiated better alternatives to continued smoking.

We have a question for them: If not by authorizing new and promising alternatives, how are they planning to reduce health problems related to smoking ? We can only conclude that, in the absence of solutions, such a prohibition could have disastrous consequences for public health.

Prohibition thumbnail

Let's have a real discussion

We understand the concerns that may be associated with new alternatives, which somewhat overturn dogma. Yet, our objective is the same as public health, our aim is to combat the high smoking-related death rate. We have facts, studies, science that prove that, although no tobacco or nicotine-based product is risk-free, our alternatives come closer to being so. We are ready, whenever those groups want to, to have a real conversation, not based on dogma and misinformation, but on facts, science and a common objective to ensure smokers healthcare.

We call on these groups to: THINK at the hundreds of millions of adults who will continue to smoke without access to better alternatives; STOP ignoring the science and evidence that doesn’t fit with their dogma; and START having a real conversation.

Some of these misguided campaigns have provided grants to media for journalism that many people believe is independent. Ultimately, this undermines the goal of tobacco harm reduction and confuses adults who smoke about better choices. And ironically, these campaigns attack a company that has publicly committed to eliminate cigarettes.

Supporting informed choices through transparency

If people who smoke are denied accurate information—or worse yet, are deceived—about less-harmful alternatives, the vast majority will simply continue to smoke cigarettes.

To set the record straight, we have addressed all of the allegations made against us by these global campaigns. Misinformation regarding our company will not be tolerated. We invite everyone to learn the facts, study our science and arrive at their own conclusions. We have nothing to hide.

crowd-of-people-zebra-crossing

Investing in a smoke-free future

We are moving as fast as we can - but, more importantly, many adult smokers are choosing to switch on their own initiative.

We have been clear about our objective to end cigarette sales. This is the future of our company; for PMI, there is no turning back. We have the determination to make it work.

The proof is in the numbers. As of March 31, 2025 :

  • C24002_Spotlight_icons_150x150_PMI_process-page_icon_150x150_1

    41 percent

    of PMI’s total global net revenues came from our smoke-free business¹.

  • C24002_Spotlight_icons_150x150_PMI_process-page_icon_150x150_6

    >41 million

    estimated total adult users of PMI’s smoke-free products¹.

  • C24002_Spotlight_icons_150x150_PMI_process-page_icon_150x150_4

    100 markets

    where our smoke-free products are available, providing better alternatives for legal-age adults¹.

  • C24002_Spotlight_icons_150x150_PMI_process-page_icon_150x150_5

    USD >14 billion

    invested to develop, scientifically substantiate, and commercialize smoke-free products since 2008².

 1 As of September 30, 2025. 2 As of December 31, 2024. Important Note: This information should be read in conjunction with the Philip Morris International Inc. earnings release dated July 22, 2025, as well as the accompanying glossary of key terms, definitions, explanatory notes, select financial information and reconciliations of non-GAAP financial measures, both of which are available on our  Investor Relations pages “PMI,” “We,” “Our,” & “Us” refers to the entire Philip Morris International family of companies.​

 

These facts are the real story.

The question for our critics is simple: Do they want to make it more difficult for adults who would otherwise continue to smoke to choose better products—or do they want to accelerate the transition away from cigarettes by embracing the potential of tobacco harm reduction, which can complement traditional tobacco control measures ?

It is easy to criticize, but it is less easy to find solutions. Our figures are encouraging, and they could be even better, if interest groups, media and governments chose to have a discussion - in order to come up with sustainable ideas - instead of attacking and criticizing without offering any other solution than letting hundred of millions of people continue to put themselves in danger

Set the record straight


25 Items

Responses

  • PMI's Response to the Financial Times' Behind the Money Podcast

    .pdf

    08/20/2025

    356 kb

  • Dr. Gilchrist’s LTE response to Matt Myers’ letter in the Washington Post

    .pdf

    08/15/2025

    46 kb

  • Dr. Gilchrist’s LTE response to Dr. Wen’s column on nicotine pouches

    .pdf

    08/15/2025

    51 kb

  • Dr. Holman’s LTE response to Dr. Wen’s column on nicotine pouches

    .pdf

    08/15/2025

    55 kb

  • PMI U.S.’s Dr. Matthew Holman responds to allegations made in Dr. Wen’s column on nicotine pouches

    .pdf

    07/29/2025

    376 kb

  • PMI’s response to The Week Unwrapped Podcast

    .pdf

    06/24/2025

    224 kb

  • PMI’s response letter to STAT News

    .pdf

    05/21/2025

    215 kb

  • PMI’s response letter to the STOP Report on HTPs

    .pdf

    05/07/2025

    294 kb

  • PMI’s response to the BBC’s article on heated tobacco products - April 2025

    .pdf

    04/28/2025

    425 kb

  • College of Physicians’ report, E-cigarettes and harm reduction, an evidence review

    .pdf

    01/29/2025

    570 kb

  • Response to OCCRP Smoke-Free Certification

    .pdf

    05/05/2022

    145 kb

  • Response to Tobacco Tactics’ Feb 2021 article “Next Generation Products: Philip Morris International”

    .pdf

    04/18/2023

    1 mb

  • Response to OCCRP article “The Sin Tax: How the Tobacco Industry’s Heated Tobacco Health Offensive is Sapping State Revenue”

    .pdf

    04/19/2023

    1 mb

  • Response to STOP: “The U.S. FDA Ruling on IQOS: Spin vs Truth”

    .pdf

    04/18/2023

    957 kb

  • Response to STOP: “FDA does not rule that IQOS reduces tobacco-related harm, yet PMI still claims victory”

    .pdf

    12/14/2020

    393 kb

  • Response to the article on Tobacco Tactics website: “PMI Promotion of IQOS Using FDA MRTP Order”

    .pdf

    12/09/2020

    366 kb

  • Correction notice to the OCCRP article “Pandering to a Pandemic”

    .pdf

    05/29/2020

    183 kb

  • Correction notice to the OCCRP article “Unsmoking for Health”

    .pdf

    05/28/2020

    206 kb

  • Correction notice to the OCCRP article “Blowing Unsmoke”

    .pdf

    05/28/2020

    196 kb

  • PMI Responses to the OCCRP

    .pdf

    05/27/2020

    225 kb

  • PMI’s further response to the Bureau of Investigative Journalism regarding donation of ventilators to the Greek government

    .pdf

    04/01/2020

    243 kb

  • PMI’s response to the Bureau of Investigative Journalism regarding donation of ventilators to the Greek government

    .pdf

    03/30/2020

    258 kb

  • Channel 4 ‘Dispatches’ programme - point-by-point response

    .pdf

    02/24/2020

    203 kb

  • Bureau of Investigative Journalism - point-by-point response

    .pdf

    02/21/2020

    234 kb

  • PMI 2017 response to Auer et al.

    .pdf

    02/26/2020

    1 mb